These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9185908)

  • 1. Epidermolytic acanthomas: clinical characteristics and immunohistochemical features.
    Cohen PR; Ulmer R; Theriault A; Leigh IM; Duvic M
    Am J Dermatopathol; 1997 Jun; 19(3):232-41. PubMed ID: 9185908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma).
    Ishida-Yamamoto A; McGrath JA; Judge MR; Leigh IM; Lane EB; Eady RA
    J Invest Dermatol; 1992 Jul; 99(1):19-26. PubMed ID: 1376754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the suprabasal keratin network by mutation M150T in the helix initiation motif of keratin 10 does not affect cornified cell envelope formation in human epidermis.
    Akiyama M; Takizawa Y; Sawamura D; Matsuo I; Shimizu H
    Exp Dermatol; 2003 Oct; 12(5):638-45. PubMed ID: 14705805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis).
    Ishida-Yamamoto A; Eady RA; Underwood RA; Dale BA; Holbrook KA
    Br J Dermatol; 1994 Dec; 131(6):767-79. PubMed ID: 7531997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
    Sundberg JP; Erickson AA; Roop DR; Binder RL
    Cancer Res; 1994 Mar; 54(5):1344-51. PubMed ID: 7509717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1.
    Sybert VP; Francis JS; Corden LD; Smith LT; Weaver M; Stephens K; McLean WH
    Am J Hum Genet; 1999 Mar; 64(3):732-8. PubMed ID: 10053007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A keratin K10 gene mutation in a Japanese patient with epidermolytic hyperkeratosis.
    Nomura K; Meng X; Umeki K; Tamai K; Sawamura D; Hashimoto I; Kikuchi T
    Jpn J Hum Genet; 1997 Mar; 42(1):217-23. PubMed ID: 9184002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis.
    Bickenbach JR; Longley MA; Bundman DS; Dominey AM; Bowden PE; Rothnagel JA; Roop DR
    Differentiation; 1996 Dec; 61(2):129-39. PubMed ID: 8983179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.
    Müller FB; Huber M; Kinaciyan T; Hausser I; Schaffrath C; Krieg T; Hohl D; Korge BP; Arin MJ
    Hum Mol Genet; 2006 Apr; 15(7):1133-41. PubMed ID: 16505000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis.
    Rothnagel JA; Fisher MP; Axtell SM; Pittelkow MR; Anton-Lamprecht I; Huber M; Hohl D; Roop DR
    Hum Mol Genet; 1993 Dec; 2(12):2147-50. PubMed ID: 7509230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and immunohistochemical analyses of keratin expression in basal cell carcinoma.
    Yoshikawa K; Katagata Y; Kondo S
    J Dermatol Sci; 1998 May; 17(1):15-23. PubMed ID: 9651824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.
    Roop DR; Krieg TM; Mehrel T; Cheng CK; Yuspa SH
    Cancer Res; 1988 Jun; 48(11):3245-52. PubMed ID: 2452688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered distribution of keratinization markers in epidermolytic hyperkeratosis.
    Ishida-Yamamoto A; Iizuka H; Manabe M; O'Guin WM; Hohl D; Kartasova T; Kuroki T; Roop DR; Eady RA
    Arch Dermatol Res; 1995; 287(8):705-11. PubMed ID: 8554380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disseminated epidermolytic acanthoma].
    Metzler G; Sönnichsen K
    Hautarzt; 1997 Oct; 48(10):740-2. PubMed ID: 9441167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated dyskeratotic acanthoma. A variant of isolated epidermolytic acanthoma.
    Roten SV; Bhawan J
    Am J Dermatopathol; 1995 Feb; 17(1):63-6. PubMed ID: 7695013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal keratin expression pattern in prurigo nodularis epidermis.
    Yang LL; Jiang B; Chen SH; Liu HY; Chen TT; Huang LH; Yang M; Ding J; He JJ; Li JJ; Yu B
    Skin Health Dis; 2022 Mar; 2(1):e75. PubMed ID: 35665210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis.
    Fuchs E; Esteves RA; Coulombe PA
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6906-10. PubMed ID: 1379726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental epidermolytic hyperkeratosis.
    Mahaisavariya P; Cohen PR; Rapini RP
    Am J Dermatopathol; 1995 Feb; 17(1):23-8. PubMed ID: 7695008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical mosaicism in a type of epidermal nevus.
    Paller AS; Syder AJ; Chan YM; Yu QC; Hutton E; Tadini G; Fuchs E
    N Engl J Med; 1994 Nov; 331(21):1408-15. PubMed ID: 7526210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel substitution in keratin 10 in epidermolytic hyperkeratosis.
    Arin MJ; Longley MA; Anton-Lamprecht I; Kurze G; Huber M; Hohl D; Rothnagel JA; Roop DR
    J Invest Dermatol; 1999 Apr; 112(4):506-8. PubMed ID: 10201536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.